Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1972 1
1975 1
1976 1
1977 3
1978 1
1979 6
1980 6
1981 7
1982 5
1983 12
1984 11
1985 7
1986 8
1987 5
1988 9
1989 14
1990 17
1991 15
1992 19
1993 14
1994 13
1995 17
1996 18
1997 12
1998 19
1999 20
2000 20
2001 23
2002 35
2003 43
2004 39
2005 72
2006 71
2007 85
2008 90
2009 101
2010 138
2011 167
2012 192
2013 198
2014 238
2015 252
2016 278
2017 314
2018 409
2019 455
2020 523
2021 640
2022 568
Text availability
Article attribute
Article type
Publication date

Search Results

4,701 results
Results by year
Filters applied: . Clear all
Page 1
COVID-19 vaccine development: milestones, lessons and prospects.
Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. Li M, et al. Among authors: tong y. Signal Transduct Target Ther. 2022 May 3;7(1):146. doi: 10.1038/s41392-022-00996-y. Signal Transduct Target Ther. 2022. PMID: 35504917 Free PMC article. Review.
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation.
Xu G, Li Y, Zhang S, Peng H, Wang Y, Li D, Jin T, He Z, Tong Y, Qi C, Wu G, Dong K, Gou J, Liu Y, Xiao T, Qu J, Li L, Liu L, Zhao P, Zhang Z, Yuan J. Xu G, et al. Among authors: tong y. Cell Res. 2021 Dec;31(12):1230-1243. doi: 10.1038/s41422-021-00578-7. Epub 2021 Oct 18. Cell Res. 2021. PMID: 34663909 Free PMC article.
Multicenter assessment of shotgun metagenomics for pathogen detection.
Liu D, Zhou H, Xu T, Yang Q, Mo X, Shi D, Ai J, Zhang J, Tao Y, Wen D, Tong Y, Ren L, Zhang W, Xie S, Chen W, Xing W, Zhao J, Wu Y, Meng X, Ouyang C, Jiang Z, Liang Z, Tan H, Fang Y, Qin N, Guan Y, Gai W, Xu S, Wu W, Zhang W, Zhang C, Wang Y. Liu D, et al. Among authors: tong y. EBioMedicine. 2021 Dec;74:103649. doi: 10.1016/j.ebiom.2021.103649. Epub 2021 Nov 20. EBioMedicine. 2021. PMID: 34814051 Free PMC article.
Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib.
Purroy N, Tong YE, Lemvigh CK, Cieri N, Li S, Parry EM, Zhang W, Rassenti LZ, Kipps TJ, Slager SL, Kay NE, Lesnick C, Shanafelt TD, Ghia P, Scarfò L, Livak KJ, Kharchenko PV, Neuberg DS, Olsen LR, Fan J, Gohil SH, Wu CJ. Purroy N, et al. Among authors: tong ye. Blood. 2022 Apr 7;139(14):2252-2256. doi: 10.1182/blood.2021013926. Blood. 2022. PMID: 35020831 No abstract available.
My writing journey.
Tong Y. Tong Y. Science. 2022 Mar 4;375(6584):1062. doi: 10.1126/science.ada1655. Epub 2022 Mar 3. Science. 2022. PMID: 35239364 No abstract available.
Molnupiravir and Its Antiviral Activity Against COVID-19.
Tian L, Pang Z, Li M, Lou F, An X, Zhu S, Song L, Tong Y, Fan H, Fan J. Tian L, et al. Among authors: tong y. Front Immunol. 2022 Apr 4;13:855496. doi: 10.3389/fimmu.2022.855496. eCollection 2022. Front Immunol. 2022. PMID: 35444647 Free PMC article. Review.
p62 works as a hub modulation in the ageing process.
Fan X, Huang T, Tong Y, Fan Z, Yang Z, Yang D, Mao X, Yang M. Fan X, et al. Among authors: tong y. Ageing Res Rev. 2022 Jan;73:101538. doi: 10.1016/j.arr.2021.101538. Epub 2021 Dec 7. Ageing Res Rev. 2022. PMID: 34890823 Review.
4,701 results